The advent of VEGF inhibitors has significantly enhanced the management of various retinal ophthalmic disorders, including proliferative diabetic retinopathy, central retinal vein occlusion, diabetic macular edema, and age-related macular degeneration [10]. Here, VEGFA is linked to age-related macular degeneration.